Montelukast Prescribing at HAVEN HEALTH
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
329
Total Quantity
13.6K
NHS Cost
£647
vs National Avg
-52%
HAVEN HEALTH prescribed 329 items of Montelukast over the last 12 months at a cost of £647 to the NHS. This is 52% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
28
Jul 2026
17
Jul 2026
36
Jul 2026
21
Jul 2026
34
Jul 2026
27
Jul 2026
34
Jul 2026
28
Jul 2026
26
Jul 2026
22
Jul 2026
29
Jul 2026
27
Prescribing Details
| Total Items | 329 |
|---|---|
| Total Quantity | 13,608 |
| Total NHS Cost | £647 |
| Presentations | 4 different forms |
| vs National Average | -52% |
Montelukast Prescribing Comparison
| This practice | 329 items |
|---|---|
| National average per practice | 685 items |
| Difference | -52% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.